Eikon Therapeutics is a pioneering biopharmaceutical company using groundbreaking microscopy technology to advance drug discovery. By directly measuring protein movement in living cells, Eikon uncovers novel drug targets and enables the creation of life-saving therapies for life-threatening diseases.
Eikon Therapeutics Highlights:
Overview
- Website: eikontx.com
- Headquarters: Hayward, California
- Employees: 380
- Founded: 2019
- Email: saereporting@eikontx.com
- Funding: $668.0M
- Revenue: $5.6M
- Valuation: n/a
Contacts
- Email: ***@eikontx.com
Similar companies
Frequently Asked Questions related to Eikon Therapeutics
Eikon Therapeutics is located in Hayward, California.
Yes, Eikon Therapeutics is a Silicon Valley company.
Eikon Therapeutics total funding is 668.0M.
Eikon Therapeutics revenue is 5.6M.
Eikon Therapeutics’s number of employees is 380.
Eikon Therapeutics’s CEO name is Roger P.
Eikon Therapeutics was founded in 2019.
Eikon Therapeutics’s contact email is saereporting@eikontx.com.
